ARTICLE | Clinical News
Phase II Argatroban trial starts
October 9, 2001 7:00 AM UTC
Texas Biotechnology (TXBI) said partner GlaxoSmithKline (GSK; LSE:GSK) started an open-label Phase II trial of Argatroban synthetic direct thrombin inhibitor in 100 patients undergoing percutaneous co...